Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol
Cadila Pharma has launched a novel drug for the treatment of high LDL cholesterol for the first time in India. To be sold under the brand name Belmore, Bempedoic acid is a one-of-its-kind drug for the treatment of high Low-Density Lipoprotein (LDL) cholesterol, also known as bad cholesterol, a company statement said.
As per published data, more than 30 per cent of adults in urban areas and 20 per cent in rural areas in India are suffering from the disease. Statins are the group of drugs used to control LDL cholesterol but in more than 80 per cent of the patients, these drugs either do not give optimum control or are not tolerated, the statement said.